Custom Search


Wednesday 01 March 2006

Olanzapine/fluoxetine combination for bipolar depression and other mood disorders: a review.

By: Owen RT.

Drugs Today (Barc) 2006 Mar;42(3):185-92

Patients with bipolar disorder tend to experience most of their illness in the depressed phase. Existing antidepressant therapies are effective in bipolar depression but carry a risk of treatment-emergent mania or increased phase cycling. Other therapies such as lithium may not be particularly effective, or may not currently be licensed for the acute phase, such as lamotrigine. A combination of the antipsychotic olanzapine and the serotonin reuptake inhibitor fluoxetine has been investigated in both bipolar depression and other affective disorders such as psychotic depression and treatment-refractory depression. The combination's possible mode of action, pharmacokinetics, drug interactions, clinical efficacy and safety and tolerability have been reviewed. Copyright 2006 Prous Science.

Use of this site is subject to the following terms of use